上市委員會譴責山東墨龍(00568.HK)及多名前管理層
香港聯合交易所上市委員會譴責山東墨龍(00568.HK),直指公司在2015及16年作披露時,未能確保財務資訊沒有誤導或欺詐成分,譴責或批評該公司創辦人兼控股股東張恩榮在內的數名前任董事違反《上市規則》或《董事承諾》,同時譴責數名前監事違反《監事承諾》。
除張恩榮,聯交所點名譴責多名山東墨龍前高層,包括前副董事長張雲三、前執行董事及財務總監楊晉、前董事長國煥然等,同時批評前非執行董事肖慶周、John Paul Cameron等。上市委員會又指令,上述數名前董事若要再獲委任為上市公司董事,須再培訓。
上市委員會認為,個案中的違規事項及行為問題嚴重,投資者長時間依據該等資料來交易,已損害市場的持正操作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.